Group 1 - The core point of the article is that Shenzhen New Industry Biomedical Engineering Co., Ltd. has received three medical device registration certificates from the Guangdong Provincial Drug Administration, including the "Placental Growth Factor Detection Kit" [1] Group 2 - The article highlights a significant shift in AI usage, with China's AI call volume surpassing that of the United States for the first time, leading to a surge in various sectors in the A-share market [1] - A well-known Wall Street analyst notes that China's computing power path is overturning traditional perceptions [1]